Citigroup’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

Citigroup’s Portfolio NITE Stock Details NITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-165,900	Closed	-$4.21M	–	7939
2019 Q1	$4.21M	Buy	+165,900	New	+$2.93M	﹤0.01%	1942
2018 Q3	–	Sell	-1,000	Closed	-$16K	–	7954
2018 Q2	$16K	Sell	1,000 -1,000	-50%	-$14.3K	﹤0.01%	7038
2018 Q1	$29K	Buy	+2,000	New	+$27.3K	﹤0.01%	6538

Citigroup's NITE Position: Q2 2019 in Review

Citigroup sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q2 2019, closing a stake of 165,900 shares — an estimated $4.21M sold.

Citigroup first reported a position in NITE in Q1 2018 and held it in 3 quarters. The position peaked at $4.21M in Q1 2019. 0 funds tracked by Wall St. Rank hold NITE as of Q2 2019.

Citigroup reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q2 2019 after selling out during the quarter.
Citigroup sold 165,900 Nightstar Therapeutics plc American Depositary Shares shares in Q2 2019, an estimated $4.21M.
Citigroup first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q1 2018 and held it in 3 quarters.
Citigroup's Nightstar Therapeutics plc American Depositary Shares position peaked at $4.21M in Q1 2019.
0 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q2 2019.

Based on Citigroup's 13F filing for Q2 2019, filed 12 Aug 2019.